Navigation Links
Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
Date:6/14/2011

SAN DIEGO, June 14, 2011 /PRNewswire/ -- Neurelis, Inc. today announced the results of a randomized crossover study in healthy volunteers assessing diazepam pharmacokinetics and bioavailability after administration of their proprietary intranasal diazepam formulations and intravenous injection. The study was designed and conducted in collaboration with investigators at the University of Minnesota. Comparative analysis of the lead intranasal formulation, NRL-1, revealed promising pharmacokinetic results.  In its evaluation of a 10mg diazepam dose in the NRL-1 intranasal solution formulation, the study showed the following:

  • NRL-1 is well-tolerated, with only mild adverse events reported
  • Similar bioavailability to intravenous administration of diazepam (100% vs. 96%)
  • Tmax of 1.5 hours.
  • Cmax of approximately 272 ng/ml.
  • These values are comparable to those reported in the literature for Diastat® (rectal diazepam gel) at equivalent doses.  Diastat is the only approved therapy for the at home treatment of acute repetitive seizures.

    • "The results from this pilot study are very encouraging," commented Jim Cloyd, PharmD, University of Minnesota professor and principal investigator of the study, "The only approved drug to treat breakthrough seizures outside the hospital is diazepam rectal gel, a therapy that many older children and adults decline to use.  The ability to quickly and efficiently deliver, via intranasal administration, clinically relevant diazepam levels offers a more acceptable method of rescue therapy. The bioavailability and relatively low variability in exposure of the intranasal diazepam solution exceeded our expectations.  We look forward to further development of this important therapy."

    Dr. Wheless, Director of the LeBonheur Comprehensive Epilepsy Program at the University of Tennessee added, "Currently, the many patients with epilepsy do not have a viable option to help
    '/>"/>

    SOURCE Neurelis, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3

    Related medicine technology :

    1. Neurelis Announces Completion of Dosing in Study of Intranasal Diazepam
    2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
    4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
    6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
    8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
    9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
    10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
    11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... , May 17, 2013  Technology advances ... communicate internally. Faced with a constantly evolving communication ... and tactics for communicating with internal executives. It ... all the strategies, tactics and tools that are ... In a new study, Best Practices, LLC explores ...
    (Date:5/17/2013)... Ill. , May 17, 2013  Sony Biotechnology Inc. ... Sorter 8-well strip holder and 130um sorting chip.  Sony will ... collected on its new SH800 Cell Sorter, the EC800 flow ... commercial tutorials at CYTO 2013, which will be held at ... San Diego, California , from May 20 ...
    (Date:5/17/2013)... 17, 2013 /PRNewswire-iReach/ -- United Medical Education, a company ... (ACLS), Pediatric Advanced Life Support (PALS) and Basic Life ... ACLS online course manuals. In order to ... to build an account with the company. By offering ... United Medical Education is setting a precedent among similar ...
    Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Delivers New Technology for Science to CYTO 2013 2ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2
    ... Calif., Nov. 17 VIVUS, Inc. (Nasdaq: VVUS ) ... phase 3 clinical trial on November 18th prior to market ... and conference call at 8:30 a.m. Eastern time. , Conference ... 1-913-312-0980 , Webcast information: http://ir.vivus.com . ...
    ... 17 AMICAS, Inc. (Nasdaq: AMCS ), a leader ... will showcase enterprise image management solutions for hospitals and integrated ... America (RSNA) annual meeting from November 29 to December 4 ... in booth #7124. , (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ...
    Cached Medicine Technology:VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results 2AMICAS' Enterprise Image Management Solutions To Be Showcased at RSNA 2009 2AMICAS' Enterprise Image Management Solutions To Be Showcased at RSNA 2009 3
    (Date:5/19/2013)... MO (PRWEB) May 19, 2013 Healthcare ... May 19-22, 2013, at the Walt Disney World Swan ... trends in supply chain innovation, care delivery and healthcare ... different dynamic in all healthcare markets, with ... of the conversation,” said Todd Ebert, Amerinet president and ...
    (Date:5/19/2013)... (PRWEB) May 19, 2013 Actos ... federal litigation now underway in U.S. District Court, Western ... Order dated May 3rd, the Court has modified the ... to eight cases rather than four. The next Status ... Thursday, May 23rd. (In re: Actos Product Liability Litigation, ...
    (Date:5/19/2013)... 2013 According to a new ... Forecast (2013 – 2018): By Applications (Healthcare (Endoscopy, ... (CCD, CMOS, Contact IS, Infrared, X-Ray) And Geography" ... market was $8.00 billion in 2012 and is ... an estimated CAGR of 3.84% from 2013 to ...
    (Date:5/19/2013)... 2013 Fat Burning Furnace developed by ... provides people with fat burning diet plans, ... Fat Burning Furnace package, people will receive the Fat ... download quickly. The Fat Burning Furnace manual includes fat ... lean muscle mass. In addition, this book covers step-by-step ...
    (Date:5/19/2013)... Dr. Keith Chertok now provides gum disease ... gums and increase the chance of a healthier smile. ... Procedure (LANAP) not only removes diseased gum tissue in patients, ... bone for dental implants. , LANAP uses a ... can also help stimulate the healthy tissue as well as ...
    Breaking Medicine News(10 mins):Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2
    ... common knowledge that in rich societies the poor have ... problem. Likewise, large inequalities of income are often regarded ... based on 30 years, research, Richard Wilkinson, Emeritus Professor ... Pickett from the University of York, go an important ...
    ... eat your broccoli: UCLA researchers report that a naturally ... may help protect against respiratory inflammation that causes conditions ... , Published in the March edition ... shows that sulforaphane, a chemical in broccoli, triggers an ...
    ... Salsa Workouts & MILK in National City Health FairSAN CLEMENTE, Calif., ... get in touch with their Latin side. Sashaying to the ... to better health. Dancing after all is a form of ... crucial to helping curb health problems like diabetes and obesity that ...
    ... Mich., March 2 NanoBio Corp. announced today that ... and preclinical milestones in the development of its novel ... The new data will be delivered in five presentations ... Dermatology in San Francisco, March 6-9, 2009. In addition ...
    ... PARK, N.C., March 2 GlaxoSmithKline (NYSE: ... influenza antiviral medication RELENZA(R) (zanamivir) Inhalation Powder ( www.RELENZA.com ... influenza season peaks. According to newly updated influenza ... for Disease Control and Prevention (CDC), the flu virus ...
    ... availability of adolescent-only services , , MONDAY, March 2 (HealthDay ... million American teens with substance abuse problems receive treatment, ... of this treatment gap may be driven by the ... of addiction programs in the U.S. have a specialized ...
    Cached Medicine News:Health News:Material success and social failure? 2Health News:Broccoli may help protect against respiratory conditions like asthma 2Health News:Drink and Dance Your Way to Health 2Health News:Drink and Dance Your Way to Health 3Health News:NanoBio to Announce Key Clinical and Preclinical Data on Its Topical Anti-infective Lotions at AAD 2009 2Health News:Ample Supplies of Relenza Available as Flu Season Peaks 2Health News:Ample Supplies of Relenza Available as Flu Season Peaks 3Health News:Teens Undertreated for Substance Abuse 2
    Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe....
    Siliconized PVC drains...
    Bard® Channel Drain...
    Used for placement of cholangiography catheters and other instruments. Supplied sterile in peel-open packages. Intended for one-time use....
    Medicine Products: